Metabolic Peptide

MOTS-c

Mitochondrial Signal • The Exercise Peptide

MOTS-c is a 16-amino-acid peptide naturally encoded by mitochondrial DNA. It acts like a mitochondrial hormone, signaling cells to improve glucose uptake, burn fuel more efficiently, and adapt to metabolic stress.

Mitochondrial DNA AMPK Performance

Protocol Snapshot

MOTS-c Quick Reference

Verified Vendors

MOTS-c

Compare Verified Vendors

Current price and availability
Price per mg and vial-size comparison
Testing and fulfillment details

Compare

View Price Index

Common Research Dose

5–10mg

Weekly total, split 3x/week

Starter Dose

500mcg

Sensitivity test before titration

Cycle Length

6–8 weeks

Followed by equal time off

Primary Pathway

AMPK Signaling

Supports glucose uptake, fat oxidation, and metabolic flexibility.

Peptide Grade

GradeB

Consistent preclinical findings support MOTS-c’s effects on metabolic flexibility, insulin sensitivity, and physical performance, reinforced by recurring community reports of steadier energy and training benefit. Controlled human trials using native MOTS-c, standardized dosing, and long-term safety data remain limited.

Research Community Safety

Foundation

Research context, mechanisms, and practical use cases

What is MOTS-c?

MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA type-c. It is a 16-amino-acid peptide that your mitochondria naturally produce. Unlike most peptides, which are encoded by nuclear DNA, MOTS-c is encoded directly within mitochondrial DNA.

MOTS-c acts as a mitochondria-derived signaling peptide and activates AMPK, often described as a metabolic master switch. That signal supports glucose uptake, fat oxidation, and metabolic adaptation. Human studies suggest circulating MOTS-c may respond more clearly to endurance exercise than resistance exercise, but the exercise response remains incompletely defined.

Signal, Not Fuel

SS-31 repairs the engine. NAD+ fuels the engine. MOTS-c sends the metabolic signal telling the engine how to perform better. This makes MOTS-c a natural fit after mitochondrial repair or alongside fuel-support strategies.

Benefits

Improved Insulin Sensitivity

MOTS-c is most strongly associated with improved glucose tolerance and insulin sensitivity in animal models, including insulin-independent glucose uptake through GLUT4 signaling.

Fat Oxidation Support

In high-fat diet models, MOTS-c helped prevent diet-induced weight gain and metabolic dysfunction by improving fuel utilization.

Physical Performance

Preclinical studies show improved running capacity, grip strength, stride length, and physical function in young and aged animals.

Healthy Aging Potential

Circulating MOTS-c levels decline with age and correlate with worsening metabolic health and reduced physical capacity.

Cardiovascular Support

Animal studies show improved cardiac function, reduced injury in ischemia-reperfusion models, and enhanced exercise-related cardiovascular adaptation.

Bone Health

MOTS-c promotes osteoblast activity and may inhibit osteoclast production through RANKL suppression in preclinical research.

Muscle Preservation

Human skeletal muscle cell research suggests MOTS-c may help preserve myotube area and reduce glucocorticoid-induced muscle-wasting signaling.

Liver Health Signals

Animal models and CB4211 human data suggest potential liver-support effects, including reductions in ALT and AST biomarkers.

What to Expect

30–60 Min — Acute Signal

Many users report a noticeable energy or performance effect when MOTS-c is taken before training.

1–2 Weeks — Energy & Endurance

Reported changes often include steadier energy, better training capacity, fewer crashes, and improved endurance.

6–8 Weeks — Metabolic Adaptation

This is the typical cycle window where improvements in body composition, recovery, glucose handling, and performance are evaluated.

Post Cycle — Reassess

Take equal time off, reassess energy, recovery, training, body composition, and glucose-related markers before repeating.

Protocol Planning

Dosing, cycling, and preparation

MOTS-c Dosing Protocol

Standard Protocol

Dose

5–10mg per week total

Frequency

Split into 3 injections per week
Monday / Wednesday / Friday

Timing

Morning fasted or before endurance/metabolic conditioning

Route

Subcutaneous injection

Duration

6–8 week cycles, then equal time off

Sensitivity & Tolerability

Initial Dose

Approximately 500mcg to assess individual tolerance

Titration

Increase gradually only when the initial dose is well tolerated

Reaction Risk

Injection-site welts, itching, and occasional hives are reported by some users

Community Practice

Taking an antihistamine beforehand is sometimes discussed, but it is not an established MOTS-c protocol and should not be used to push through a worsening reaction

Match Timing to the Training Goal

MOTS-c activates AMPK in preclinical research, supporting glucose uptake, fat oxidation, and metabolic adaptation. Because strong AMPK signaling can temporarily oppose mTORC1 signaling, users prioritizing hypertrophy may prefer not to dose immediately before heavy resistance training. A better mechanistic fit is before endurance, cardio, circuits, kettlebell work, or other metabolic-conditioning sessions. This timing strategy is based on pathway biology—not a controlled human MOTS-c timing trial.

MOTS-c Reconstitution

10mg Vial

Diluent

2mL bacteriostatic saline

Concentration

5mg/mL

500mcg

10 units on a U-100 syringe

1mg

20 units on a U-100 syringe

Handling Notes

Preferred Option

Bacteriostatic saline may reduce irritation for sensitive users

Alternative

Bacteriostatic water can also be used

Agitation

Gently swirl; do not shake aggressively

Storage

Refrigerate after reconstitution

Reconstitution Calculator

Anecdotal Data Points

Community-reported outcomes and recurring patterns

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Positive Reports

Some users report a noticeable energy boost within approximately 30 minutes, particularly when used before training.
Energy is often described as steadier and more sustained, with fewer crashes than stimulant-based products.
Improved endurance and greater training capacity are recurring reports.
Fat loss is described as easier when MOTS-c accompanies caloric restriction and regular training, especially alongside retatrutide or semaglutide.

Negative Reports

Injection-site reactions—including redness, itching, raised welts, or firm bumps—are frequently discussed, with some users reporting reactions that persist longer than expected.
Responses vary substantially, with some users reporting little or no noticeable effect.
Older, sedentary, or metabolically unhealthy users sometimes describe slower or weaker effects than regular exercisers and metabolically healthier users.

Stacking & Synergy

Potential MOTS-c pairings and tracking context

Stacking & Synergy

MOTS-c + NAD+

NAD+ is the fuel for the energy system that MOTS-c is optimizing. MOTS-c pushes metabolic signaling; NAD+ supports the raw material needed for energy production.

MOTS-c + 5-Amino-1MQ

5-Amino-1MQ inhibits NNMT, helping reduce NAD+ waste. In the engine analogy, it helps fix the exhaust leak so fuel is recycled more efficiently.

MOTS-c + GLP-1s

Retatrutide, semaglutide, and tirzepatide handle the intake side through appetite and gastric emptying. MOTS-c supports cellular fuel utilization.

MOTS-c + SS-31

If mitochondrial dysfunction is significant, repair first with SS-31. If decline is moderate, concurrent use may be reasonable.

Signal + Fuel + Efficiency

MOTS-c sends the signal, NAD+ supplies the fuel, and 5-Amino-1MQ helps preserve fuel availability. This makes MOTS-c central to a broader mitochondrial optimization stack.

Free with login

Track in Journal

Compare dose timing against training output, glucose trends, and injection-site tolerance.

Dose, timing, and training type.
Energy, endurance, and recovery.
Glucose trends and injection reactions.

Start Tracking

Safety Notes

Side effects, contraindications, and precautions

Side Effects

The closest human safety data comes from CB4211, a stabilized MOTS-c analog. In Phase 1a/1b testing, it was generally well tolerated with no serious adverse events reported, although native MOTS-c itself still has limited direct human safety data.

Most side-effect information for native MOTS-c comes from user reports rather than large controlled human trials.

Common User Reports

Injection-site redness, swelling, bruising, or mild irritation.
Temporary fatigue or lethargy during early use.
Mild headache.
Changes in appetite, either lower or higher.

Less Common Reports

Hives or allergic-type injection reactions.
Heart palpitations.
Sleep disruption, especially when dosed late.
Symptoms consistent with low blood sugar in susceptible users.

Contraindications & Precautions

Do Not Use If You Have

Active cancer or tumors.
Type 1 diabetes, because effects on glucose handling could increase hypoglycemia risk.
Known hypersensitivity to MOTS-c or any formulation component.

Use Caution With

Type 2 diabetes treated with insulin or glucose-lowering medications.
Pregnancy or breastfeeding, because safety data is unavailable.
Any serious chronic illness or history of cancer.
History of allergic reactions to injectable peptides.

Drug Interactions

Glucose-lowering medications may compound the insulin-sensitizing and glucose-uptake effects of MOTS-c. Blood sugar should be monitored closely, and medication adjustments should only be made with a qualified clinician.

Regulatory Status

MOTS-c is not FDA approved for human use and is not legal for sale as a drug, food, or dietary supplement in the United States. It is also prohibited by WADA as a metabolic modulator and AMPK activator.

Tested athletes should not use MOTS-c.

FINAL VERDICT

Peptide Protocol's Opinionated Opinion

This is not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

MOTS-c is one of the highest-ROI peptides in the mito/longevity category right now. This mitochondrial-derived peptide punches way above its weight for energy, fat oxidation, and metabolic flexibility. Community feedback and preclinical research consistently point to better endurance, improved insulin sensitivity, and faster recovery from metabolic stress—exactly what serious recomp and performance stacks need.

It’s not a hype peptide; it’s a tool. The strong AMPK activation makes it ideal pre-cardio, endurance work, or high-heart-rate circuits such as HIIT or CrossFit-style training. Avoid it right before heavy, pure hypertrophy sessions if maximal mTOR drive is the goal—that AMPK/mTOR interplay is real.

The only reason it doesn’t get a better grade is that injection-site reactions are real and should be monitored closely. A cycle can be going well and then, seemingly out of nowhere, a serious reaction such as hives can occur. If hives or another serious reaction occurs, treat it as a warning shot and stop using the compound.